Intestinal Neoplasms
25
3
5
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.0%
1 terminated out of 25 trials
88.9%
+2.4% vs benchmark
12%
3 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (25)
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
CRC Detection Reliable Assessment With Blood
Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment
SGM-101 in Colorectal Brain Metastases.
Application of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients.
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
Spanish Series of Patients Treated With the Radionuclide Lutetium177
Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Usefulness of GI-GENIUS in FIT-based Colorectal Cancer Screening Program.
Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer
Study of Small Bowel Tumor With Dual-phase Enhanced Computed Tomography (CTE) and Magnetic Resonance Enterography (MRE)
Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection
Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)
A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC
Low Rectal Cancer Study (MERCURY II)
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks